Some scientists have recently proposed dihydroorotate dehydrogenase (DHODH) as an attractive HBAT for the development of broad-spectrum antivirals, which provides more treatment options for COVID-19 through its dual mechanism of antiviral action and immune system regulation [25]. Here, DHODH is linked to COVID-19.